The clinical utility of faecal calprotectin in patients with differentiated and undifferentiated spondyloarthritis: Relevance and clinical implications

Emad, Yasser; Ragab, Yasser; Hammam, Nevin; El-Shaarawy, Nashwa; Fawzi, Magdy; Amer, Arwa; El-Makhzangy, Hesham; Ismail, Ahmed; Ibrahim, Ossama; Hassan, Yosra.
Reumatol. clín. (Barc.) ; 18(2): 69-76, Feb 2022. ilus, tab, graf
Artículo en Inglés | IBECS (España) | ID: ibc-204788

Documentos relacionados

  1. Muscle microRNAs in the cerebrospinal fluid predict clinical response to nusinersen therapy in type II and type III spinal muscular atrophy patients.
  2. Epigenetics in the treatment of systemic lupus erythematosus: potential clinical application.
  3. Systems analysis of miRNA biomarkers to inform drug safety.
  4. Hematologic parameters as biomarkers for antihistamine and omalizumab resistance in chronic spontaneous urticaria.
  5. Doxorubicin targets multiple players: A new view of an old problem.
  6. Improving drug safety: From adverse drug reaction knowledge discovery to clinical implementation.
  7. Obstructive sleep apnea is a determinant of asthma control independent of smoking, reflux, and rhinitis.
  8. Potential Roles of Extracellular Vesicles as Biomarkers and a Novel Treatment Approach in Multiple Sclerosis.
  9. Therapeutic target database update 2014: a resource for targeted therapeutics.
  10. Nonclinical Development of Biologics: Integrating Safety, Pharmacokinetics, and Pharmacodynamics to Create Smarter and More Flexible Nonclinical Safety Programs Optimizing Animal Use.